Virological and immunological response to HAART regimen containing integrase inhibitors in HIV-2-infected patients
- 12 March 2008
- journal article
- other
- Published by Wolters Kluwer Health in AIDS
- Vol. 22 (5) , 665-666
- https://doi.org/10.1097/qad.0b013e3282f51203
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohortAIDS, 2006
- Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapyJournal of Antimicrobial Chemotherapy, 2006
- Improved Sensitivity of Human Immunodeficiency Virus Type 2 Subtype B Plasma Viral Load AssayJournal of Clinical Microbiology, 2005
- Highly Active Antiretroviral Therapy and Viral Response in HIV Type 2 InfectionClinical Infectious Diseases, 2004
- Susceptibility of HIV-2, Siv and Shiv to Various Anti-HIV-1 Compounds: Implications for Treatment and Postexposure ProphylaxisAntiviral Therapy, 2004
- Plasma RNA Viral Load in Human Immunodeficiency Virus Type 2 Subtype A and Subtype B InfectionsJournal of Clinical Microbiology, 2002